Strikingly low prevalence of pituitary incidentalomas in a teaching hospital in Uruguay.
head imaging
headaches
image
pituitary adenoma
pituitary incidentaloma
prevalence
sellar mass
Journal
Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782
Informations de publication
Date de publication:
2023
2023
Historique:
received:
06
07
2023
accepted:
07
09
2023
medline:
1
11
2023
pubmed:
13
10
2023
entrez:
13
10
2023
Statut:
epublish
Résumé
Pituitary incidentalomas are an occurrence documented in 10.6% of post-mortem examinations, 4%-20% of computed tomography (CT) scans, and 10%-38% of magnetic resonance imaging (MRI) cases, primarily consisting of microincidentalomas (<1 cm in size). However, the prevalence of pituitary incidentalomas in Uruguay remains unexplored. This study aimed to ascertain the prevalence of pituitary incidentalomas at our hospital. In this investigation, we retrospectively identified patients who underwent brain CT and MRI at our hospital over a 1-year span due to conditions other than suspected or known pituitary disorders. The time frame covered was from 1 January to 31 December 2017. Our analysis encompassed all scans, and we conducted interviews with patients discovered to have pituitary incidentalomas. Furthermore, we conducted biochemical assessments in accordance with clinical and imaging traits. During the study period, a total of 3,894 patients underwent imaging procedures. Of these, 1,146 patients underwent MRI scans, and 2,748 underwent CT scans. The mean age was 53.1 ± 19 years, with a relatively even distribution between genders (50.6% women). The majority of imaging requisitions originated from the emergency department (43%), followed by outpatient clinics (29%), and inpatient wards (28%). Common reasons for imaging requests included trauma (20.4%), headaches (11.3%), and stroke (10.9%). Among these cases, two pituitary incidentalomas were detected, resulting in a prevalence of 5 cases per 10,000 individuals annually (0.051%). Both of these cases were initially identified through CT scans, with subsequent MRI scans performed for further assessment. The final diagnoses were a vascular aneurysm and a sellar meningioma, with the latter patient also exhibiting secondary hypothyroidism. Notably, no instances of pituitary adenomas were encountered. The prevalence of pituitary incidentalomas within our hospital was notably low. Further research is necessary to more comprehensively investigate the occurrence of pituitary incidentalomas in our country.
Sections du résumé
Background
Pituitary incidentalomas are an occurrence documented in 10.6% of post-mortem examinations, 4%-20% of computed tomography (CT) scans, and 10%-38% of magnetic resonance imaging (MRI) cases, primarily consisting of microincidentalomas (<1 cm in size). However, the prevalence of pituitary incidentalomas in Uruguay remains unexplored. This study aimed to ascertain the prevalence of pituitary incidentalomas at our hospital.
Methods
In this investigation, we retrospectively identified patients who underwent brain CT and MRI at our hospital over a 1-year span due to conditions other than suspected or known pituitary disorders. The time frame covered was from 1 January to 31 December 2017. Our analysis encompassed all scans, and we conducted interviews with patients discovered to have pituitary incidentalomas. Furthermore, we conducted biochemical assessments in accordance with clinical and imaging traits.
Results
During the study period, a total of 3,894 patients underwent imaging procedures. Of these, 1,146 patients underwent MRI scans, and 2,748 underwent CT scans. The mean age was 53.1 ± 19 years, with a relatively even distribution between genders (50.6% women). The majority of imaging requisitions originated from the emergency department (43%), followed by outpatient clinics (29%), and inpatient wards (28%). Common reasons for imaging requests included trauma (20.4%), headaches (11.3%), and stroke (10.9%). Among these cases, two pituitary incidentalomas were detected, resulting in a prevalence of 5 cases per 10,000 individuals annually (0.051%). Both of these cases were initially identified through CT scans, with subsequent MRI scans performed for further assessment. The final diagnoses were a vascular aneurysm and a sellar meningioma, with the latter patient also exhibiting secondary hypothyroidism. Notably, no instances of pituitary adenomas were encountered.
Conclusions
The prevalence of pituitary incidentalomas within our hospital was notably low. Further research is necessary to more comprehensively investigate the occurrence of pituitary incidentalomas in our country.
Identifiants
pubmed: 37829684
doi: 10.3389/fendo.2023.1254180
pmc: PMC10565029
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1254180Informations de copyright
Copyright © 2023 Pineyro, Sosa, Rivero, Tripodi, Negrotto and Lima.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Cancer. 2004 Aug 1;101(3):613-9
pubmed: 15274075
Pituitary. 2014 Oct;17(5):486-91
pubmed: 24052242
J Clin Endocrinol Metab. 2011 Apr;96(4):905-12
pubmed: 21474687
Injury. 2014 May;45(5):840-4
pubmed: 24252575
Neuroendocrinology. 2020;110(7-8):595-603
pubmed: 31525736
Clin Endocrinol (Oxf). 2007 Dec;67(6):938-43
pubmed: 17692109
PLoS One. 2016 Mar 07;11(3):e0151080
pubmed: 26950220
Eur J Endocrinol. 2015 Nov;173(5):655-64
pubmed: 26423473
Clin Endocrinol (Oxf). 1999 Jul;51(1):109-13
pubmed: 10469480
Neuroradiology. 1986;28(2):161-5
pubmed: 3703239
J Clin Endocrinol Metab. 2011 Jun;96(6):1633-41
pubmed: 21470998
Surg Neurol. 2005 Jun;63(6):550-3; discussion 553
pubmed: 15936382
J Trauma. 2007 Jan;62(1):157-61
pubmed: 17215748
Eur J Endocrinol. 2016 Jul;175(1):1-9
pubmed: 27037179
Endocr Relat Cancer. 2008 Dec;15(4):885-903
pubmed: 18809592
Eur J Endocrinol. 2003 Aug;149(2):123-7
pubmed: 12887289
JAMA. 1990 May 23-30;263(20):2772-6
pubmed: 2332920
Radiology. 1982 Jul;144(1):109-13
pubmed: 7089241
Expert Rev Endocrinol Metab. 2010 Mar;5(2):253-264
pubmed: 30764049
Am J Med Sci. 1997 Nov;314(5):287-91
pubmed: 9365329
Int J Oral Maxillofac Implants. 2012 May-Jun;27(3):595-603
pubmed: 22616053
Presse Med. 2021 Dec;50(4):104081
pubmed: 34687911
Indian J Pathol Microbiol. 2011 Oct-Dec;54(4):692-4
pubmed: 22234092
J Emerg Trauma Shock. 2015 Apr-Jun;8(2):77-82
pubmed: 25949036
Radiology. 1997 Jan;202(1):41-6
pubmed: 8988190
J Clin Endocrinol Metab. 2000 May;85(5):1789-93
pubmed: 10843153
Emerg Med Int. 2011;2011:624847
pubmed: 22046542
Best Pract Res Clin Endocrinol Metab. 2009 Oct;23(5):667-75
pubmed: 19945030
J Endocr Soc. 2020 Nov 29;5(2):bvaa186
pubmed: 33392424
PLoS One. 2013 Aug 15;8(8):e71467
pubmed: 23967214
N Engl J Med. 2007 Nov 1;357(18):1821-8
pubmed: 17978290
Eur Radiol. 2013 Mar;23(3):816-26
pubmed: 22911290
Endocrinol Metab Clin North Am. 1999 Mar;28(1):81-117, vi
pubmed: 10207686
Int J Clin Pract. 2011 Feb;65(2):172-7
pubmed: 21235697
J Clin Endocrinol Metab. 2011 Apr;96(4):894-904
pubmed: 21474686
Ann Intern Med. 1994 May 15;120(10):817-20
pubmed: 8154641
J Clin Endocrinol Metab. 2010 Sep;95(9):4268-75
pubmed: 20534753
Eur J Endocrinol. 2023 Jul 20;189(1):87-95
pubmed: 37345849
World Neurosurg. 2022 Feb;158:e843-e855
pubmed: 34838770
AJR Am J Roentgenol. 1984 Aug;143(2):377-81
pubmed: 6611072
AJNR Am J Neuroradiol. 1994 Apr;15(4):675-9
pubmed: 8010269
Curr Pain Headache Rep. 2018 Jul 4;22(8):57
pubmed: 29974273
Endocr Pract. 2023 Jan;29(1):60-68
pubmed: 36270609
Neuroradiology. 2022 Mar;64(3):633
pubmed: 35022801